Evergreen Nephrology Strengthens Value-Based Kidney Care With Strong CMS Results and Physician Leadership Push

Evergreen Nephrology focused this week on reinforcing its value-based kidney care model through stronger physician leadership, robust government program results, and an expanded emphasis on patient education. The company highlighted its Evergreen Physicians Leadership Council as a key forum where network nephrologists help shape programs to improve provider alignment and patient outcomes.

Evergreen reported strong 2024 performance in the CMS Kidney Care Choices program, generating more than $40 million in Medicare savings and ranking second nationally among Kidney Contracting Entities in net savings. Its network produced about $225 in Medicare savings per patient per month, supported over $35 million in quality-linked performance payments, and achieved a 2.3% net shared savings rate with 24% year-over-year growth in payouts.

Clinically, the company cited a 58% optimal start rate for kidney replacement therapy, delayed progression to kidney failure in 35% of a tracked stage 4 chronic kidney disease cohort, and a 25% higher transplant access rate than the national average. Management framed these outcomes as validation that early intervention and coordinated care can align quality with predictable shared savings under value-based contracts.

Evergreen also underscored patient education as a central pillar of its model, offering high-touch support such as medication clarification, symptom management, and connections to social and emotional resources. This approach is intended to complement nephrologists’ care, deepen patient engagement, and potentially reduce costly hospitalizations while strengthening performance in risk-based arrangements.

The company further invested in relationship-building with nephrologists through its presence at the RPA 2026 conference in Atlanta, including hosting events to deepen ties and support referral networks. Together, these initiatives suggest Evergreen is consolidating its position as a leading outcomes-focused platform in value-based kidney care, with improving CMS results and growing physician alignment supporting its long-term operating outlook.